Comparing two imaging techniques for detecting arterial obstructions in stroke patients
Official title: Accuracy of Transcranial Colour Coded Duplex Compared With CT Angiography in Diagnosing Arterial Obstructions in Acute Ischemic Strokes
Run by Sohag University · NCT06920303 · Data updated 2026-11-12
This study is testing whether a new imaging method called TCCD is better than CT angiography for finding blocked arteries in stroke patients, especially in the Egyptian population.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | January 1, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | May 13, 2025 |
| Trial ID | NCT06920303 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients presenting with acute ischemic strokes or transient ischemic attacks.
✕Probably not a fit
Patients with a history of cardiac arrhythmia, autoimmune diseases, or those with significant neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the accuracy of transcranial colour coded duplex (TCCD) in comparison to CT angiography for detecting arterial obstructions in patients who have experienced acute ischemic strokes or transient ischemic attacks. The study focuses on understanding the prevalence of intracranial stenosis and its implications in different ethnic groups, particularly in the Egyptian population, where data is scarce. By assessing the effectiveness of TCCD, the study seeks to provide insights into a potentially less invasive imaging method for stroke diagnosis. The findings could enhance the understanding of stroke mechanisms and improve diagnostic approaches in clinical settings.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic accuracy for ischemic strokes, potentially allowing for better-targeted treatments.
How similar studies have gone: While there is extensive data on carotid atherosclerosis in various populations, this study's focus on the Egyptian ethnic group represents a novel approach that has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients who have acute ischemic strokes or transient ischemic attacks . Exclusion Criteria: 1. Patients with history of cardiac arrhythmia or discovered recently or known rheumatic heart disease. 2. Patients with history of autoimmune diseases. 3. Patients with space occupying lesion or hemorrhage in Ct brain. 4. Pregnant female. 5. Patients who refuse to participate in the study. 6. Patients who have history of allergy or developed acute kidney injury during previous dye injection. 7. Patients who have chronic kidney disease. 8. Premorbid neurological disorder (myopathy, multiple sclerosis) on neurological examination or previous investigations. 9. Inability to achieve safe vascular access. 10. Patients with insufficient temporal acoustic window.
Where it's running
-
Sohag university hospital
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Hassan H Accuracy of Transcranial Colour Coded duplex Compared With CT, resident
- Email: hassan.hamdy@med.sohag.edu.eg
- Phone: +2001060583440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered decision support to boost thrombolysis for ischemic stroke
This trial tests whether an AI-assisted decision tool helps doctors give intravenous thrombolysis to eligible ischemic stroke patients within 24 hours at a primary hospital in China, compared with standard care.
-
Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy
This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.
-
Intra-arterial Thrombolysis for Acute Ischemic Stroke with Medium Vessel Occlusion
This trial tests whether delivering a clot-busting medicine directly into the brain’s medium vessels helps improve outcomes for adults with acute ischemic stroke caused by MeVO, on top of standard care.
-
Single Bolus Non-immunogenic Staphylokinase in Acute Ischemic Stroke (4.5–24 hours)
This trial tests a single 10 mg bolus of non-immunogenic staphylokinase versus placebo in adults with acute ischemic stroke 4.5–24 hours after onset to see if it helps restore blood flow and improve outcomes.
-
Imaging to detect impaired microcirculatory reperfusion after clot removal
This project tests whether CT perfusion scans done after clot removal can spot poor tiny-vessel blood flow in adults with large-vessel ischemic stroke.
-
Cerebrolysin for early rehabilitation after acute ischemic stroke
This trial tests whether adding Cerebrolysin to standard early rehabilitation helps people with moderate acute ischemic stroke recover arm and overall function faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.